Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00508950
NCT00508950
Completed
Not Applicable

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Pneumococcal Opsonophagocytic Assay Development.

Pfizer1 site in 1 country152 target enrollmentAugust 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Pfizer
Enrollment
152
Locations
1
Primary Endpoint
To identify potential serum donors and obtain unit volumes of blood from these donors for use in pneumococcal opsonophagocytic assay development.
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The study will identify healthy adults who have been vaccinated against pneumococcus, and collect blood for the purpose of developing laboratory assays.

Detailed Description

Collect serum with antibody levels capable of killing pneumococcal bacteria from healthy prevaccinated adults to develop OPA assays for the 13 serotypes in 13-valent pneumococcal conjugate vaccine.

Registry
clinicaltrials.gov
Start Date
August 2007
End Date
June 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Pfizer
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Healthy adults 18-70 years of age
  • •Must have received 23vPS pneumococcal vaccine

Exclusion Criteria

  • •Bleeding diathesis
  • •Pregnancy
  • •Chronic disease which could be worsened by donating blood
  • •Receipt of blood, blood products or immune globulin within six months

Outcomes

Primary Outcomes

To identify potential serum donors and obtain unit volumes of blood from these donors for use in pneumococcal opsonophagocytic assay development.

Time Frame: 8 years

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay DevelopmentHealthy Subjects
NCT00401232Pfizer955
Recruiting
Not Applicable
Blood Sampling of Healthy Volunteers for Immunological ResearchHealthy Volunteers
NCT03819829The Netherlands Cancer Institute50
Completed
Not Applicable
A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological AssaysImmunologic Tests
NCT01099488GlaxoSmithKline46
Unknown
Not Applicable
Bone Marrow Collection in Healthy Volunteers (iCell)Spinal Cord Injury
NCT02118740Amarna Stem Cells BV15
Recruiting
Phase 4
Blood Donor CVD 5000Risk Reduction
NCT03971669University of Maryland, Baltimore150